A07AA01 neomycin

ALIMENTARY TRACT AND METABOLISM ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS INTESTINAL ANTIINFECTIVES Antibiotics

非健保收載 TFDA 在效許可證 4 FDA 已核准

台灣藥品與外觀

台灣食藥署在效西藥許可證 4 張;以下列出 4 個品項(1 項有外觀照)。

無外觀照
"西德有機"新黴素膠囊250毫克
無外觀照
"人人"新黴素膠囊250公絲
紐奧黴素膠囊250公絲 外觀
紐奧黴素膠囊250公絲
膠囊 · 棕;;;橘 · 刻痕:無 · 21 mm
無外觀照
"紐約"新黴素錠

資料來源:食藥署「西藥許可證」+「藥品 ATC 碼」+「藥品外觀」+「藥品仿單或外盒」開放資料。外觀照與仿單連結指向食藥署原始檔。

適應症

台灣 TFDA 核准適應症

  1. 腸外科痔瘡、肛門等手術前、腸道之消毒殺菌、細菌性痢疾、沙門氏菌、志賀氏菌、阿米巴、埃希氏大腸桿菌等所致傳染性腸炎、瀉痢。
  2. 細菌性痢疾、沙門氏菌、志賀氏菌、阿米巴原蟲等所致感染性腸炎。
  3. 手術前或肝昏迷之病人用於腸道局部殺菌。
  4. 革蘭氏陽性菌及革蘭氏陰性菌之感染症。

美國 FDA 適應症(英文原文對照)

美國 FDA 核准成分 neomycin sulfate, polymyxin b sulfate and dexamethasone (商品名 Antibiotic / Antibiotic and Pain Relief / CareALL Triple Antibiotic plus Pain Relief / Careland Triple Antibiotic / DG Health Antibiotic / DG Health Triple Antibiotic) · 仿單更新 2026-03-18

INDICATIONS AND USAGE For steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial infection exists. Ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of corticosteroids use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. They are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns; or penetration of foreign bodies. The use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. The particular anti-infective drug in this product is active against the following common bacterial eye pathogens: Staphylococcus aureus, Escherichia coli, Haemophilus influenzae , Klebsiella /Enterobacter species, Neisseria species, and Pseudomonas aeruginosa . This product does not provide adequate coverage against: Serratia marcescens and S treptococci , including Streptococcus pneumoniae .

資料來源:食藥署西藥許可證適應症(中文)、openFDA US SPL(英文,僅供對照)。

健保給付規定

查無健保特殊給付規定條款;本藥品依一般健保藥品支付規定給付。

實證補充

本藥品尚無實證補充整理(未來新增 Review/指引知識時補列)。


台灣藥品與適應症:食藥署西藥許可證+ATC+外觀+仿單開放資料 · FDA:openFDA US SPL · 健保給付:健保署「全民健康保險藥品給付規定」(更新日 2026-06-09)· 實證補充:人工彙整。 本頁為資訊整理,實際給付與適應症以主管機關公告為準。